Published in Lancet on January 11, 2000
European clinical guidelines for hyperkinetic disorder -- first upgrade. Eur Child Adolesc Psychiatry (2004) 3.22
Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev (2006) 2.96
Psychopharmacology: concepts and opinions about the use of stimulant medications. J Child Psychol Psychiatry (2009) 1.91
Global 5-HT depletion attenuates the ability of amphetamine to decrease impulsive choice on a delay-discounting task in rats. Psychopharmacology (Berl) (2003) 1.73
Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings. J Neurodev Disord (2012) 1.73
Attention-deficit/hyperactivity disorder and attention networks. Neuropsychopharmacology (2010) 1.69
Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress. Neuropsychopharmacology (2010) 1.62
Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter. Proc Natl Acad Sci U S A (2008) 1.52
Neuroimaging and fetal alcohol spectrum disorders. Dev Disabil Res Rev (2009) 1.51
Circadian modulation of dopamine levels and dopaminergic neuron development contributes to attention deficiency and hyperactive behavior. J Neurosci (2015) 1.51
Assessment and management of attention-deficit hyperactivity disorder in adults. CMAJ (2003) 1.47
Animal models of attention-deficit hyperactivity disorder. Behav Brain Funct (2005) 1.47
ADHD and smoking: from genes to brain to behavior. Ann N Y Acad Sci (2008) 1.46
The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders. Br J Pharmacol (2011) 1.39
Towards conceptualizing a neural systems-based anatomy of attention-deficit/hyperactivity disorder. Dev Neurosci (2009) 1.39
Attention-Deficit Hyperactivity Disorder in the post-genomic era. Eur Child Adolesc Psychiatry (2004) 1.36
Understanding decision-making deficits in neurological conditions: insights from models of natural action selection. Philos Trans R Soc Lond B Biol Sci (2007) 1.35
Modulation of high impulsivity and attentional performance in rats by selective direct and indirect dopaminergic and noradrenergic receptor agonists. Psychopharmacology (Berl) (2011) 1.22
Gray matter alterations in adults with attention-deficit/hyperactivity disorder identified by voxel based morphometry. Biol Psychiatry (2010) 1.15
Methylphenidate facilitates learning-induced amygdala plasticity. Nat Neurosci (2010) 1.09
An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children followed to adulthood. Am J Med Genet B Neuropsychiatr Genet (2006) 1.09
Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1). BMC Genet (2005) 1.08
Basal ganglia surface morphology and the effects of stimulant medications in youth with attention deficit hyperactivity disorder. Am J Psychiatry (2010) 1.08
Candidate genes and neuropsychological phenotypes in children with ADHD: review of association studies. J Psychiatry Neurosci (2009) 1.07
ADHD outside the laboratory: boys' executive function performance on tasks in videogame play and on a visit to the zoo. J Abnorm Child Psychol (2002) 1.07
Common human 5' dopamine transporter (SLC6A3) haplotypes yield varying expression levels in vivo. Cell Mol Neurobiol (2006) 1.05
Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse. CNS Neurol Disord Drug Targets (2008) 1.03
The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder. Eur Child Adolesc Psychiatry (2005) 1.03
Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD). Psychopharmacology (Berl) (2008) 1.01
Subtypes of attention-deficit/hyperactivity disorder (ADHD): distinct or related disorders across measurement levels? Child Psychiatry Hum Dev (2006) 0.98
[(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain. Eur J Nucl Med Mol Imaging (2003) 0.96
Age and sex differences in the locomotor effect of repeated methylphenidate in rats classified as high or low novelty responders. Psychopharmacology (Berl) (2006) 0.95
Ingestion of Mn and Pb by rats during and after pregnancy alters iron metabolism and behavior in offspring. Neurotoxicology (2011) 0.95
Sequence analysis of Drd2, Drd4, and Dat1 in SHR and WKY rat strains. Behav Brain Funct (2005) 0.94
Assessing methylphenidate preference in ADHD patients using a choice procedure. Psychopharmacology (Berl) (2004) 0.93
Attentional and neurocognitive characteristics of high-risk offspring of parents with schizophrenia compared with DSM-IV attention deficit hyperactivity disorder children. Schizophr Res (2005) 0.92
Dopamine transporter genotype predicts implicit sequence learning. Behav Brain Res (2010) 0.92
Experimental analyses of gene-brain-behavior relations: some notes on their application. J Appl Behav Anal (2001) 0.92
Misrepresentation of neuroscience data might give rise to misleading conclusions in the media: the case of attention deficit hyperactivity disorder. PLoS One (2011) 0.92
Functional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects. Biol Psychiatry (2012) 0.91
Influence of methylphenidate on brain development--an update of recent animal experiments. Behav Brain Funct (2006) 0.91
Pharmacotherapy for attention-deficit/hyperactivity disorder: from cells to circuits. Neurotherapeutics (2012) 0.89
Methylphenidate increases cigarette smoking in participants with ADHD. Psychopharmacology (Berl) (2011) 0.89
Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder. Addiction (2014) 0.89
Why most biomedical findings echoed by newspapers turn out to be false: the case of attention deficit hyperactivity disorder. PLoS One (2012) 0.88
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease. Pharmacol Rev (2015) 0.88
Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders. J Biomed Biotechnol (2012) 0.87
Altered pattern of brain dopamine synthesis in male adolescents with attention deficit hyperactivity disorder. Behav Brain Funct (2006) 0.87
Clinical correlations of grey matter reductions in the caudate nucleus of adults with attention deficit hyperactivity disorder. J Psychiatry Neurosci (2010) 0.86
Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transporters. AAPS J (2005) 0.86
Catechol-O-methyltransferase (COMT) Val108/158 Met polymorphism does not modulate executive function in children with ADHD. BMC Med Genet (2004) 0.85
Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD. Eur Arch Psychiatry Clin Neurosci (2005) 0.85
Maternal separation affects dopamine transporter function in the spontaneously hypertensive rat: an in vivo electrochemical study. Behav Brain Funct (2011) 0.85
Smoking behaviour and mental health disorders--mutual influences and implications for therapy. Int J Environ Res Public Health (2013) 0.85
Stimulant medication and prefrontal functional connectivity during working memory in ADHD: a preliminary report. J Atten Disord (2010) 0.84
The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography. JAMA Psychiatry (2014) 0.83
Acute and sub-chronic functional neurotoxicity of methylphenidate on neural networks in vitro. J Neural Transm (Vienna) (2007) 0.83
Impaired transcallosally mediated motor inhibition in adults with attention-deficit/hyperactivity disorder is modulated by methylphenidate. J Neural Transm (Vienna) (2008) 0.83
Potential programming of dopaminergic circuits by early life stress. Psychopharmacology (Berl) (2010) 0.82
A New Outlook on Mental Illnesses: Glial Involvement Beyond the Glue. Front Cell Neurosci (2015) 0.80
Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD. J Neural Transm (Vienna) (2010) 0.80
Neurogenetic interactions and aberrant behavioral co-morbidity of attention deficit hyperactivity disorder (ADHD): dispelling myths. Theor Biol Med Model (2005) 0.80
Noise benefit in prepulse inhibition of the acoustic startle reflex. Psychopharmacology (Berl) (2010) 0.80
Medial temporal lobe functioning and structure in the spontaneously hypertensive rat: comparison with Wistar-Kyoto normotensive and Wistar-Kyoto hypertensive strains. Hippocampus (2010) 0.80
Gamification of Cognitive Assessment and Cognitive Training: A Systematic Review of Applications and Efficacy. JMIR Serious Games (2016) 0.80
Differential expression of SLC9A9 and interacting molecules in the hippocampus of rat models for attention deficit/hyperactivity disorder. Dev Neurosci (2012) 0.79
DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics. Pharmgenomics Pers Med (2010) 0.79
Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder. Neurochem Int (2013) 0.79
Homovanillic acid (HVA) plasma levels inversely correlate with attention deficit-hyperactivity and childhood neglect measures in addicted patients. J Neural Transm (Vienna) (2007) 0.79
Effect of dioxins on regulation of tyrosine hydroxylase gene expression by aryl hydrocarbon receptor: a neurotoxicology study. Environ Health (2009) 0.78
ADHD in adolescence and adulthood, with a special focus on the dopamine transporter and nicotine. Dialogues Clin Neurosci (2006) 0.78
Connectivity differences between adult male and female patients with attention deficit hyperactivity disorder according to resting-state functional MRI. Neural Regen Res (2016) 0.77
Immunization with DAT fragments is associated with long-term striatal impairment, hyperactivity and reduced cognitive flexibility in mice. Behav Brain Funct (2012) 0.77
A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD. Behav Brain Funct (2008) 0.77
Dopamine-transporter density in patients with ADHD. Lancet (2000) 0.77
Attention-deficit/hyperactivity disorder in older adults: prevalence and possible connections to mild cognitive impairment. Curr Psychiatry Rep (2012) 0.77
An integrated feature ranking and selection framework for ADHD characterization. Brain Inform (2016) 0.76
Dopamine transporter gene susceptibility to methylation is associated with impulsivity in nonhuman primates. J Neurophysiol (2014) 0.76
Acute oral administration of low doses of methylphenidate targets calretinin neurons in the rat septal area. Front Neuroanat (2015) 0.75
Decision making: effects of methylphenidate on temporal discounting in nonhuman primates. J Neurophysiol (2015) 0.75
Increased locomotor activity and non-selective attention and impaired learning ability in SD rats after lentiviral vector-mediated RNA interference of Homer 1a in the brain. Int J Med Sci (2012) 0.75
Dopamine-transporter density in patients with ADHD. Lancet (2000) 0.75
Poor replication validity of biomedical association studies reported by newspapers. PLoS One (2017) 0.75
Word recognition memory in adults with attention-deficit/hyperactivity disorder as reflected by event-related potentials. Front Hum Neurosci (2011) 0.75
Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT. Eur J Nucl Med Mol Imaging (2004) 0.75
Masked presentations of emotional facial expressions modulate amygdala activity without explicit knowledge. J Neurosci (1998) 7.85
Response and habituation of the human amygdala during visual processing of facial expression. Neuron (1996) 5.93
Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat Neurosci (1998) 3.71
The emotional counting Stroop paradigm: a functional magnetic resonance imaging probe of the anterior cingulate affective division. Biol Psychiatry (1998) 3.20
A functional MRI study of human amygdala responses to facial expressions of fear versus anger. Emotion (2001) 3.15
Imaging amyloid deposition in Lewy body diseases. Neurology (2008) 3.09
Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol Psychiatry (1999) 2.95
An fMRI study of anterior cingulate function in posttraumatic stress disorder. Biol Psychiatry (2001) 2.95
Toward a neurobiology of obsessive-compulsive disorder. Neuron (2000) 2.89
Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry (1994) 2.70
Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance. Biol Psychiatry (2000) 2.68
Differential prefrontal cortex and amygdala habituation to repeatedly presented emotional stimuli. Neuroreport (2001) 2.60
The counting Stroop: an interference task specialized for functional neuroimaging--validation study with functional MRI. Hum Brain Mapp (1998) 2.52
Regional cerebral blood flow during script-driven imagery in childhood sexual abuse-related PTSD: A PET investigation. Am J Psychiatry (1999) 2.35
Differential response in the human amygdala to racial outgroup vs ingroup face stimuli. Neuroreport (2000) 2.29
Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am (2000) 2.24
Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry (1995) 2.22
A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch Gen Psychiatry (1996) 2.22
Conscious recollection and the human hippocampal formation: evidence from positron emission tomography. Proc Natl Acad Sci U S A (1996) 2.09
Clinical correlates of ADHD in females: findings from a large group of girls ascertained from pediatric and psychiatric referral sources. J Am Acad Child Adolesc Psychiatry (1999) 2.07
Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther (1989) 2.04
Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry (1999) 2.03
When magic bullets ricochet. J Nucl Med (1990) 2.01
Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med (1990) 1.92
The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med (1994) 1.80
High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res (2000) 1.80
Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry (1996) 1.77
111In-labeled nonspecific immunoglobulin scanning in the detection of focal infection. N Engl J Med (1989) 1.76
The influence of gonadal hormones on conditioned fear extinction in healthy humans. Neuroscience (2010) 1.69
Managing the patient with treatment-resistant obsessive compulsive disorder: current strategies. J Clin Psychiatry (1994) 1.67
Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse. Circulation (1998) 1.64
Test-retest reliability of a functional MRI working memory paradigm in normal and schizophrenic subjects. Am J Psychiatry (2001) 1.59
Neural substrates of anorexia nervosa: a behavioral challenge study with positron emission tomography. J Pediatr (2001) 1.58
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
Cerebral structural abnormalities in obsessive-compulsive disorder. A quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry (1996) 1.56
Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J Am Acad Child Adolesc Psychiatry (1996) 1.55
Magnetic resonance image-guided stereotactic cingulotomy for intractable psychiatric disease. Neurosurgery (1996) 1.53
Visual imagery and perception in posttraumatic stress disorder. A positron emission tomographic investigation. Arch Gen Psychiatry (1997) 1.52
The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation. Biol Psychiatry (1997) 1.52
Asparagine synthetase activity of mouse leukemias. Science (1968) 1.49
A method for assessing the accuracy of intersubject registration of the human brain using anatomic landmarks. Neuroimage (1999) 1.48
The stimulants revisited. Child Adolesc Psychiatr Clin N Am (2000) 1.48
Simplified measurement of deoxyglucose utilization rate. J Nucl Med (1996) 1.48
Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder. Am J Psychiatry (1997) 1.47
Improvement in severe self-mutilation following limbic leucotomy: a series of 5 consecutive cases. J Clin Psychiatry (2001) 1.45
Localization of radiolabeled chemotactic peptide at focal sites of Escherichia coli infection in rabbits: evidence for a receptor-specific mechanism. J Nucl Med (1997) 1.42
Polymorphisms in the 3'-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry (2002) 1.39
Serum tryptophan level after carbohydrate ingestion: selective decline in non-albumin-bound tryptophan coincident with reduction in serum free fatty acids. Life Sci II (1973) 1.38
Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology (1995) 1.35
Anti-hyperactivity medication: methylphenidate and amphetamine. Mol Psychiatry (1998) 1.35
Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18. AJNR Am J Neuroradiol (1995) 1.31
Prefrontal regions supporting spontaneous and directed application of verbal learning strategies: evidence from PET. Brain (2001) 1.30
Characteristics of memory dysfunction in body dysmorphic disorder. J Int Neuropsychol Soc (2000) 1.30
The discovery of an unusually selective and novel cocaine analog: difluoropine. Synthesis and inhibition of binding at cocaine recognition sites. J Med Chem (1994) 1.28
Functional neuroanatomy of antisaccade eye movements investigated with positron emission tomography. Proc Natl Acad Sci U S A (1995) 1.27
Activation of anterior paralimbic structures during guilt-related script-driven imagery. Biol Psychiatry (2000) 1.27
A mu-opioid receptor single nucleotide polymorphism in rhesus monkey: association with stress response and aggression. Mol Psychiatry (2004) 1.25
Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective. Psychol Med (2011) 1.25
Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry (2006) 1.24
Sensory phenomena in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry (2000) 1.22
Organizational strategies mediate nonverbal memory impairment in obsessive-compulsive disorder. Biol Psychiatry (1999) 1.22
Visual Mental Imagery Activates Topographically Organized Visual Cortex: PET Investigations. J Cogn Neurosci (1993) 1.21
Sapap3 and pathological grooming in humans: Results from the OCD collaborative genetics study. Am J Med Genet B Neuropsychiatr Genet (2009) 1.21
A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. Am J Psychiatry (1999) 1.20
Investigating the pathogenesis of posttraumatic stress disorder with neuroimaging. J Clin Psychiatry (2001) 1.20
A positron emission tomographic study of simple phobic symptom provocation. Arch Gen Psychiatry (1995) 1.20
Anger in healthy men: a PET study using script-driven imagery. Biol Psychiatry (1999) 1.19
Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry (1996) 1.19
Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum. Synapse (1991) 1.18
Accumulation of immunoglobulin G at focal sites of inflammation. Eur J Nucl Med (1992) 1.17
A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry (2001) 1.16
Relevance of free tryptophan in serum to tissue tryptophan concentrations. Metabolism (1974) 1.16
Combining methylphenidate and clonidine: a clinically sound medication option. J Am Acad Child Adolesc Psychiatry (1999) 1.15
The role of hippocampus and frontal cortex in age-related memory changes: a PET study. Neuroreport (1996) 1.15
Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies. Clin Cancer Res (2001) 1.15
Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results. Cell Transplant (2000) 1.14
Letter: Dietary carbohydrate increases brain tryptophan and decreases free plasma tryptophan. Nature (1973) 1.13
Probing striatal function in obsessive-compulsive disorder: a PET study of implicit sequence learning. J Neuropsychiatry Clin Neurosci (1997) 1.12
Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior. J Pharmacol Exp Ther (1989) 1.10
Distinguishing illness severity from tic severity in children and adolescents with Tourette's disorder. J Am Acad Child Adolesc Psychiatry (2000) 1.10
Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia. Arch Gen Psychiatry (1999) 1.10
Reduced basal ganglia volumes in trichotillomania measured via morphometric magnetic resonance imaging. Biol Psychiatry (1997) 1.09
Neuroimaging and neurobiological models of depression. Harv Rev Psychiatry (1998) 1.09
Neural effects of visualizing and perceiving aversive stimuli: a PET investigation. Neuroreport (1996) 1.08
Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology (2005) 1.07
Identifying objects seen from different viewpoints. A PET investigation. Brain (1994) 1.07
Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology (2000) 1.07
Cocaine induced secretion of ACTH, beta-endorphin, and corticosterone. Peptides (1988) 1.07
Antecedents and complications of trauma in boys with ADHD: findings from a longitudinal study. J Am Acad Child Adolesc Psychiatry (1999) 1.06
Preclinical evaluation and phase I clinical trial of a 99mTc-labeled synthetic polymer used in blood pool imaging. AJR Am J Roentgenol (1998) 1.05
Strategic processing and episodic memory impairment in obsessive compulsive disorder. Neuropsychology (2000) 1.04
Functional MRI and the study of OCD: from symptom provocation to cognitive-behavioral probes of cortico-striatal systems and the amygdala. Neuroimage (1996) 1.04